[11]Kurozumi S, Padilla M, Kurosumi M, et al. HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients. Breast Cancer Res Treat. 2016;158(1):99-111. [12]van Mackelenbergh MT, Loibl S, Untch ...
HR)、人表皮生长因子受体2(human epidermal growth factor receptor 2,HER-2)及细胞周期调节蛋白-67(Ki-67)表达水平,临床上乳腺癌主要分为4种预后不同的亚型:Luminal A型、Luminal B型、人表皮生长因子受体2(HER-2)阳性型和三阴型乳腺癌(triple...
[11]Kurozumi S,et al.HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients.Breast Cancer Res Treat 2016;158:99–111. [12]Parker JS,et al.Supervised Risk Predictor of Breast Cancer Based on Intrins...
[8]Rosso, C. & Voutsadakis, I. A. Characteristics, clinical differences and outcomes of breast cancer patients with negative or low HER2 expression. Clin. Breast Cancer 22, 391–397 (2022). [9]Agostinetto, E. et al...
[7] Agostinetto E, Rediti M, Fimereli D, et al. HER2-low breast cancer: molecular characteristics and prognosis. Cancers (Basel) 2021;13(11):2824. [8] Spring LM, Barlow WE, Bardia A, et al. Impact of HER2 low status on clinical outcomes in participants with 1-3 positive lymph no...
TRIPLE-negative breast cancerHER2 proteinNEOADJUVANT chemotherapyBREAST cancer prognosisBackground and purpose: Human epidermal growth factor receptor 2 (HER2) is one of the main markers affecting the prognosis of breast cancer patients and the most important re...
Chen Y, Chen S, Li Q, Cai R, Wang J, Luo Y, Fan Y, Yuan P, Zhang P, Li Q, Ma F, Xu B. In real life, low-level HER2 expression may be associated with better outcome in HER2-negative breast cancer: a study of the national cancer center, China. Front Oncol. 2022;11:774577...
[5]Yoon KH, Park Y, Kang E, et al. Effect of estrogen receptor expression level and hormonal therapy on prognosis of early breast cancer[J]. Cancer Res Treat, 2021 [Ahead of print]. [6]Chen T, Zhang N, Moran MS, et al. Borderline ER-positive primary breast cancer gains no signific...
2,Darlix A, Louvel G, et al. Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort. Br J Cancer. 2019 Dec;121(12):991-1000. ...
[5] Horisawa, N. et al. The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status. Breast Cancer 29, 234–241. [6] Tan, R. S. Y. C. et al. HER2 expression, copy number variatio...